-
Nvidia-Backed Recursion Pharmaceuticals Stock Is Up On Q1 Earnings: Everything You Need To Know
Thursday, May 9, 2024 - 5:25pm | 485Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares are rising in Thursday’s after-hours session following the company’s first-quarter financial results. Q1 Earnings: Recursion reported first-quarter revenue of $13.491 million, which beat analyst estimates of $12.65 million, according to...
-
What's Next For Nvidia And Mellanox?
Tuesday, March 12, 2019 - 5:00pm | 724GPU inventor NVIDIA Corporation (NASDAQ: NVDA) reached an agreement to acquire Israel-based Mellanox Technologies, Ltd. (NASDAQ: MLNX), a supplier of smart interconnect solutions and services for servers and storage for $125 per share. Several more Street analysts have offered their take. The...